Amplia Therapeutics Limited (INNMF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 12:11PM EDT
| Previous Close | 0.0487 |
| Open | 0.0487 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0487 - 0.0487 |
| 52 Week Range | 0.0250 - 0.1000 |
| Volume | |
| Avg. Volume | 5,541 |
| Market Cap | 9.721M |
| Beta (5Y Monthly) | 0.52 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | May 28, 2024 - Jun 03, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireFDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US
Amplia Therapeutics Limited (ASX: ATX), ("Amplia" or the "Company"), is pleased to announce that the US FDA have cleared Amplia's IND application for a trial of Amplia's best-in-class focal adhesion kinase (FAK) inhibitor narmafotinib in pancreatic cancer. The proposed trial will explore the safety, tolerability and efficacy of a combination of narmafotinib with the chemotherapy regime FOLFIRINOX.
© 2024 Yahoo. All rights reserved.